By Zachary Visconti Posted on December 19, 2023 Rivian has selected a construction firm to build its new production facility located outside of Atlanta,...

By Zachary Visconti Posted on December 10, 2023 Rivian is laying off some of its in-house battery workers at its factory in Normal, Illinois,...

Saxena, M., van der, Burg, S. H., Melief, C. J. M. & Bhardwaj, N. Therapeutic cancer vaccines. Nat. Rev. Cancer 21, 360–378 (2021).Article  ...

Sign up for daily news updates from CleanTechnica on email. Or follow us on Google News! ONE (Our Next Energy) is a battery company based...

Anion exchange membrane fuel cells (AEMFCs) have gained attention in the process of fuel cell development because they operate in alkaline environments, the redox...

Generation of a P-iKO hESC lineTo understand the role of arginine methylation in pancreatic endocrine cell development, we generated a PRMT1-inducible knockout (P-iKO) hESC...

Imagine using your cell phone to control the activity of your own cells to treat injuries and disease. It sounds like something from the...

We’ve all seen the ever-growing selection of CBD and hemp-infused skincare products that are “taking the market by storm”, but what people may not...

Everyone watched the Tesla Investor Day livestream with bated breath to see the company’s new affordable vehicle, the Model 2 — and waited and...

Listen to this article If you ask Thomas Hofmann, a project manager for BMW’s hydrogen fuel cell program, what he’d...

Tesla battery supplier LG Energy Solutions announced it would build a $1.4 billion battery production facility in Arizona as demand for electric vehicles throughout the United States skyrockets. LG Energy Solutions said it would build the $1.4 billion plant to meet demand for “prominent startups” and other North American companies as consumer sentiment is beginning […]

The post Tesla battery supplier LG Energy Solutions announces $1.4B battery factory in Arizona appeared first on TESLARATI.

Founded in 2019, SeaBeLife is a biotech startup developing drug candidates to block cell necrosis. Today, it’s announced a funding boost of almost €1.4 million financing from Bpifrance.  SeaBeLife specialises in the development of drug candidates that block cellular necrosis in order to protect or regenerate organs affected by severe pathologies – for which there […]

The post Brittany-based biotech startup SeaBeLife picks up €1.4 million appeared first on EU-Startups.